Skip to main navigation menu Skip to main content Skip to site footer

FORMULASI DAN EVALUASI TABLET KUNYAH BERBASIS BAHAN ALAM: SEBUAH REVIEW ARTIKEL

Abstract

Chewable tablets are one of the oral pharmaceutical dosage forms developed to improve patient convenience and medication adherence, particularly among children, older adults, and individuals who experience difficulty swallowing conventional tablets. The utilization of natural materials as active ingredients in chewable tablet formulations has continued to expand due to their diverse bioactive compounds with potential pharmacological activities. This review article aimed to examine the development of the formulation and evaluation of naturalbased chewable tablets by analyzing 25 scientific articles published between 2021 and 2026. The study employed a literature review method by collecting and analyzing relevant articles from various scientific databases. The reviewed aspects included the types of natural materials, formulation methods, excipient composition, physical quality evaluation, and biological activities of the formulations. The findings indicated that wet granulation and direct compression were the most commonly used manufacturing methods. Excipients such as mannitol, microcrystalline cellulose (MCC), sorbitol, CMC-Na, gelatin, and carrageenan played important roles in producing chewable tablets with satisfactory physical quality. Furthermore, most natural materials contained bioactive compounds, including flavonoids, phenolic compounds, alkaloids, terpenoids, tannins, saponins, essential oils, and β- carotene, which contributed to various pharmacological activities. Overall, natural-based chewable tablets demonstrate considerable potential for further development as effective, safe, practical, and patient-friendly pharmaceutical and nutraceutical dosage forms.

Keywords

chewable tablets, evaluation, formulation, natural ingredients

PDF

References

  1. Andarifera, A. Z., Zaini, E., Yosmar, R., & Fitriani, L. (2025). Formulation and physical
  2. characterization of chewable gummy from galangal rhizome extract (Kaempferia galanga
  3. L.) as a nutraceutical product. Jurnal Sains Farmasi & Klinis, 12(2), 145–155.
  4. https://doi.org/10.25077/jsfk.12.2.145-155.2025
  5. Banik, B., Sharma, A., & Nasrin, A. (2021). Development and evaluation of carminative herbal
  6. chewable tablets based on turmeric, fennel seed, and mango ginger. Asian Pacific Journal
  7. of Health Sciences, 8(3), 141–145. https://doi.org/10.21276/apjhs.2021.8.3.24
  8. Development, F., et al. (2024). Formulation development and evaluation of riboflavin chewable
  9. tablet using Moringa oleifera gum powder for taste masking and better patient compliance.
  10. 11(1), 324–336.
  11. Gemilang, N. P., Jayani, N. I. E., & Rani, K. C. (2023). Formulation of chewable gummy tablet
  12. of Moringa oleifera L. leaf extract using combination kappa carrageenan and iota
  13. carrageenan. In Proceedings (Vol. 2022). Atlantis Press. https://doi.org/10.2991/978-94-
  14. 6463-322-1_21
  15. Ghurghure, S. M., Pathan, M. S. A., Surwase, P. R., Shirure, P. D., & Gote, P. M. (2023).
  16. Formulation and evaluation of chewable tablets containing aqueous extract of Zingiber
  17. officinale. World Journal of Pharmacy and Pharmaceutical Sciences, 8(3), 1416–1424.
  18. https://doi.org/10.20959/wjpps20193-13328
  19. Haque, A. F., Mulyani, E., Fauziah, D. W., & Joeis, J. (2023). Formulasi tablet kunyah dari
  20. minyak atsiri jeruk kalamansi (Citrofortunella microcarpa) dengan variasi pemanis sorbitol.
  21. SINTA Journal (Science, Technology, and Agricultural), 4(1), 51–58.
  22. https://doi.org/10.37638/sinta.4.1.51-58
  23. Huang, X., et al. (2025). Chewable tablets containing rape bee pollen and maca attenuate
  24. testosterone propionate-induced benign prostatic hyperplasia in Sprague–Dawley rats by
  25. regulating the gut microbiota and modulating the IL-6/JAK2/STAT3 signaling pathway.
  26. Frontiers in Microbiology, 16, 1–16. https://doi.org/10.3389/fmicb.2025.1547724
  27. Hurkadale, P. J., Channi, N. M., Bolmal, U. B., Bidikar, C. M., & Hj, P. (2023). Formulation
  28. design and optimization of poly-herbal chewable tablets using JMP tool. 2, 1–11.
  29. https://doi.org/10.35702/Pharmacogn.10003
  30. Karaoğlu, Ö., et al. (2023). Chewable tablet with herbal extracts and propolis arrests Wuhan
  31. and Omicron variants of SARS-CoV-2 virus. Journal of Functional Foods, 105.
  32. https://doi.org/10.1016/j.jff.2023.105544
  33. Karthick, S., Vasanthan, A., & Senthilkumar, K. L. (2024). Formulation and evaluation of
  34. chewable tablet of Solanum nigrum L. leaf extract. 2(4), 1265–1280.
  35. https://doi.org/10.5281/zenodo.11092173
  36. Khairnar, M., Desale, D., Kale, S., Deore, H., Bhadane, D., & Shaikh, S. (n.d.). Formulation and
  37. evaluation of chewable tablets of Catharanthus roseus leaf. 2(4), 22–31.
  38. Khairnar, U., Chole, R., Hire, R., & Bharti, G. (2025). Development of a novel herbal chewable
  39. tablet for dental caries treatment. International Journal of Scientific Research and
  40. Technology, 2(1), 423–431.
  41. Lestari, U., Novra, A., & Kurniadi, R. (2025). Chewable tablet formulation from ethanol extracts of betel, areca, and gambir as a substitute for betel. Jurnal Jamu Indonesia, 10(1), 49–54.
  42. https://doi.org/10.29244/jji.v10i1.311
  43. Mankar, S. D., Musale, P., Bhawar, S. B., Siddheshwar, S. S., & Dighe, S. B. (2024). Exploring
  44. the synergistic effect in polyherbal chewable antacid tablets: Formulation and evaluation
  45. study. Current Issues in Pharmacy and Medical Sciences, 37(3), 153–161.
  46. https://doi.org/10.2478/cipms-2024-0025
  47. Matulyte, I., Mataraite, A., Velziene, S., & Bernatoniene, J. (2021). The effect of Myristica
  48. fragrans on texture properties and shelf-life of innovative chewable gel tablets.
  49. Pharmaceutics, 13(2), 1–15. https://doi.org/10.3390/pharmaceutics13020238
  50. P. Gigi. (2026). Formulasi dan uji efektivitas tablet kunyah ekstrak kulit kayu manis
  51. (Cinnamomum burmannii) sebagai inovasi sediaan. 3, 7–8.
  52. Patil, J., Vishwajith, V., & Gopal, V. (2021). Formulation development and evaluation of
  53. chewable tablets containing non-sedating antihistamine. Journal of Pharmaceutical and
  54. Scientific Innovation, 1(3), 112–117.
  55. Pratama, N. P., Purnomo Sari, K. R., & Kurniawati, E. (2022). Formulation of chewable tablet
  56. preparations from the combination of Azadirachta indica A. Juss. and Gynura procumbens
  57. (Merr.). Jurnal Farmasi Sains dan Praktis, 8(1), 124–133.
  58. https://doi.org/10.31603/pharmacy.v8i1.5918
  59. Putthong, C., Panmanee, T., Charoensit, P., Ross, S., Tongpoolsomjit, K., & Viyoch, J. (2025).
  60. Efficacy of natural β-carotene chewable tablets derived from banana (Musa AA) pulp in
  61. reducing UV-induced skin erythema. Nutrients, 17(1), 1–13.
  62. https://doi.org/10.3390/nu17010065
  63. Rani, K. C., Jayani, N. I. E., Setaratika, M., & Dewi, S. M. K. (2023). Optimization of sucrose
  64. and propylene glycol concentration in the formulation of chewable gummy tablets of
  65. Moringa oleifera leaf extract. BIOEDUSCIENCE, 7(1), 73–87.
  66. https://doi.org/10.22263/j.bes/7110751
  67. Rustiani, E., Widayanti, K., & Zaddana, C. (2022). IX(1), 63–70.
  68. Rustiani, E., Zulkarnaen, D. M. Z., & Andini, S. (2024). Formulasi tablet kunyah kombinasi
  69. tepung cangkang telur dan ekstrak daun kelor (Moringa oleifera L.). Majalah Farmasetika,
  70. 9(7), 83–96. https://doi.org/10.24198/mfarmasetika.v9i7.58884
  71. Sawant, A., Ghube, S., Parab, V., Sawant, A., & Rawool, G. (2026). Formulation and evaluation
  72. of Tanacetum parthenium chewable tablets for anti-migraine activity. 4(3), 3334–3347.
  73. https://doi.org/10.5281/zenodo.19230545
  74. Utami, A. S., Nawangsari, D., & Setianingsih, S. (2024). Effect of CMC-Na concentration as a
  75. binder in the formulation of chewable tablets of ethanol extract of onion tubers (Allium
  76. cepa L.). Health and Biological Science ICHBS, 247–264.
  77. Verkhovod, V. M., & Kovalevska, I. V. (2026). The development of a tablet formulation of
  78. quercetin with carrot extract with improved solubility for the prevention of
  79. atherosclerosis. 111, 36–4

Similar Articles

1-10 of 28

You may also start an advanced similarity search for this article.